Ephedra
This article was originally published in The Tan Sheet
Executive Summary
Separate letter in same issue of NEJM from Ephedra Education Council consultant Grover Hutchins, MD, charges Christine Haller, MD, and Neal Benowitz, MD, ignored subjects' preexisting conditions when conducting their review of ephedra AEs. Authors reply ephedra still is "unreasonably dangerous" since it can lead to severe health problems in vulnerable populations, especially among those unaware of their underlying condition